Table 3.
Median and 5-year overall survival in relation to CD30 and Ki-67 expression analyzed as dichotomous variables.
| CD 30 epidermis | CD 30 dermis | Ki-67 epidermis | Ki-67 dermis | |||||
|---|---|---|---|---|---|---|---|---|
| < median | > median | < median | > median | < median | > median | < median | > median | |
|
Survival from onset of rash |
||||||||
| Median (months) |
75 | 91.5 | 93.5 | 80 | 103.5 | 75 | 158 | 67 |
| 5-year survival | 73% | 91% | 86% | 80% | 94% | 70% | 100% | 65% |
| p-value * | ns | 0.028 | 0.054 | 0.001 | ||||
|
Survival from time of diagnosis |
||||||||
| Median (months) |
49.5 | 65 | 59 | 50.5 | 71.5 | 44 | 90 | 36 |
| 5-year survival | 69% | 83% | 87% | 63% | 95% | 55% | 100% | 44% |
| p-value * | ns | 0.015 | 0.032 | 0.001 | ||||
|
Survival from time of biopsy |
||||||||
| Median (months) |
49.5 | 59 | 59 | 50 | 68.5 | 41 | 79 | 36 |
| 5-year survival | 70% | 83% | 87% | 64% | 95% | 56% | 100% | 46% |
| p-value * | ns | 0.014 | 0.022 | <0.001 | ||||
*
Log-rank (Mantel-Cox)